한글목차

세계의 발/발목용 기기 시장 규모는 2024년 48억 3,000만 달러에서 2032년에 84억 5,000만 달러에 달할 것으로 예측되며, 예측 기간인 2025-2032년에 CAGR로 7.24%의 성장이 전망됩니다. 시장은 노년 인구의 증가, 저침습수술의 수요 증가, 기술의 진보 증가에 의해 예측 기간에도 견고한 성장이 전망되고 있습니다.

발/발목용 기기는 발 및 발목에 영향을 미치는 부상이나 변형 등의 증상을 치료하는 데 사용되는 의료기기입니다. 이 보조기는 발/족관절의 구조뿐만 아니라 기능도 유지합니다. 정형외과 질환의 유병률 증가, 노령 인구 증가, 의료 기술의 발전이 발/족관절용 보조기 시장을 주도하고 있습니다. 또한 스포츠 부상 및 외상 증가, 당뇨병 및 비만과 같은 생활습관병과 같은 요인도 발/족관절 임플란트, 보조기 및 보조기 수요를 더욱 증가시킬 것으로 예상됩니다. 시장 확대의 또 다른 요인은 혁신적인 환자 맞춤형 솔루션과 최소 침습 수술 기법의 채택입니다. 예를 들어 Johnson & Johnson Services, Inc. 산하 DePuy Synthes는 2024년 9월 발/족관절 수술용 TriLEAP 하지 해부학 플레이트 시스템(TriLEAP)을 출시했으며, TriLEAP 시스템은 전족부 및 중족부 외상 및 재건 수술에 사용되는 다양한 스쿼트 및 재건 수술을 목표로 합니다. 다양한 스크류 옵션을 통해 유연성을 제공합니다. 또한 성인과 청소년 모두에게 혜택을 줄 수 있는 전족부 수술 및 족관절 재건 수술용 포트폴리오를 강화합니다. 발/발목용 기기 시장은 정부 지원 정책 및 유리한 상환 정책으로 인해 더욱 확대되고 있습니다.

세계의 발/발목용 기기 시장에 대해 조사분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업의 상황 등을 제공하고 있습니다.

목차

제1장 프로젝트 범위와 정의

제2장 조사 방법

제3장 개요

제4장 세계의 발/발목용 기기 시장 전망(2018-2032년)

• 시장 규모 분석과 예측
  • 금액
• 시장 점유율 분석과 예측
  • 제품별
  • 용도별
  • 최종사용자별
  • 지역별
  • 시장 점유율 분석 : 기업별(금액)(상위 5사와 기타 - 2024년)
• 시장 맵 분석(2024년)
  • 제품별
  • 용도별
  • 최종사용자
  • 지역별

제5장 북미의 발/발목용 기기 시장 전망(2018-2032년)

• 시장 규모 분석과 예측
  • 금액
• 시장 점유율 분석과 예측
  • 제품별
  • 용도별
  • 최종사용자별
  • 점유율 : 국가별
• 각국의 시장 평가
  • 미국의 발/발목용 기기 시장 전망(2018-2032년)
  • 캐나다
  • 멕시코

제6장 유럽의 발/발목용 기기 시장 전망(2018-2032년)

• 독일
• 프랑스
• 이탈리아
• 영국
• 러시아
• 네덜란드
• 스페인
• 폴란드

제7장 아시아태평양의 발/발목용 기기 시장 전망(2018-2032년)

• 인도
• 중국
• 일본
• 호주
• 베트남
• 한국
• 인도네시아
• 필리핀

제8장 남미의 발/발목용 기기 시장 전망(2018-2032년)

• 브라질
• 아르헨티나

제9장 중동 및 아프리카의 발/발목용 기기 시장 전망(2018-2032년)

• 사우디아라비아
• 아랍에미리트
• 남아프리카공화국
• 이스라엘

제10장 수급 분석

제11장 밸류체인 분석

제12장 Porter's Five Forces 분석

제13장 PESTLE 분석

제14장 가격 분석

제15장 시장 역학

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제

제16장 시장의 동향과 발전

제17장 규제 구조와 혁신

• 규제기관의 승인
• 혁신

제18장 특허 상황

제19장 사례 연구

제20장 경쟁 구도

• 시장 리더 상위 5사의 경쟁 매트릭스
• 상위 5사의 SWOT 분석
• 주요 기업 상위 10사의 상황
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Arthrex, Inc.
  • Johnson & Johnson Services, Inc.
  • Smith & Nephew plc.
  • Exactech, Inc.
  • Acumed LLC
  • Enovis Corporation
  • Fillauer Companies, Inc.

제21장 전략적 추천

제22장 Market Xcel - Markets and Data 소개·면책사항

영문목차

Global foot and ankle devices market is projected to witness a CAGR of 7.24% during the forecast period 2025-2032, growing from USD 4.83 billion in 2024 to USD 8.45 billion in 2032. The global foot and ankle devices market is expected to keep growing robustly during the forecast period owing to an increasing geriatric population, increasing demand for minimally invasive surgery, and increasing technological advancement.

Foot and ankle devices are medical devices used in treating conditions such as injuries and deformities or other conditions affecting the foot and ankle. The device maintains the structure as well as the function of the foot and ankle. An increasing prevalence of orthopedic disorders, an increasing geriatric population, and advancements in medical technologies drive the foot and ankle devices market. Other factors, such as increased sports-related injuries, trauma cases, and lifestyle-related conditions like diabetes and obesity, will further drive the demand for foot and ankle implants, orthotics, and braces. Other expansion factors in the market include the adoption of minimally invasive surgical techniques coupled with innovative and patient-specific solutions. For instance, in September 2024, DePuy Synthes, part of Johnson & Johnson Services, Inc., launched the TriLEAP lower extremity anatomic plating system for foot and ankle surgery. TriLEAP system is aimed to be utilized trauma and reconstructive procedures in the forefoot and midfoot, offering flexibility with various screw options. It enhances the portfolio for first-ray surgery and foot and ankle reconstruction, benefiting both adults and adolescents. The market is further expanding with supporting government policies and favorable reimbursement growth in the foot and ankle devices market.

Increasing Prevalence of Foot and Ankle Disorder Boosts Market Growth

The growing prevalence of foot and ankle joint diseases such as osteoarthritis, rheumatoid arthritis, Achilles tendinitis, etc., due to the increasing geriatric population, sedentary lifestyle, and rising obesity levels are the key factors driving the market growth. According to the data published by the CDC in June 2024, an estimated 58.5 million US adults aged >=18 years have arthritis, and the number is expected to reach 78 million by 2040. The report stated that 25.7 million people were diagnosed with arthritis-attributable activity limitation in 2023. Moreover, sports injuries and injury-related incidents are also rising, driving the demand for advanced foot and ankle devices. Increasing awareness about the importance of early diagnosis of diseases and proper treatment has led to increased use of orthopedic implants, orthopedic devices, and orthopedic products.

Rising Awareness and Technological Developments Drive Market Growth

Rising awareness and technological developments in foot and ankle devices are growth drivers propelling the global foot and ankle device market. Increased patient education and awareness of advanced treatment options have led to the adoption of devices that would include implants, orthotics, and braces for managing different foot and ankle conditions. This is further compounded by the fact that enormous technological breakthroughs in the field of 3D printing, biocompatible materials, and robotic-assisted surgical instruments are transforming the design of devices and impacting clinical results. This interplay between increasing knowledge and advanced technologies opens up avenues in growth markets through resultant demand for more effective, customizable, and convenient foot and ankle treatments globally. For instance, in September 2024, Enovis Corporation unveiled its Tarsoplasty percutaneous Lapidus system at the American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting. These innovations, along with other advanced products, reinforce Enovis commitment to improving patient outcomes and surgical efficiency, positioning the company as a leader in the evolving foot and ankle market.

Soft Tissue Orthopedic Devices Segment to Dominate the Foot and Ankle Devices Market

The soft tissue orthopedic devices segment is expected to capture the maximum market share in the foot and ankle devices market, led by an increasing incidence of sports-related injuries, growth in the prevalence of musculoskeletal disorders, and developments in minimally invasive surgical technologies. Advancements in invasive surgical techniques and the rising adoption of soft tissue repair solutions like tendon and ligament repair products, resulting in improved patient outcomes and shorter recovery time, also enhance the dominance of this product segment. Also, the increasing demand for innovative biologics and synthetic materials to improve repair durability is supposed to boost market growth. For instance, in January 2024, Paragon 28, Inc. launched the Grappler knotless anchor system and Bridgeline tape, strengthening its position in the growing foot and ankle soft tissue market. The Grappler system offers a comprehensive, sterile kit for tendon and ligament repairs, designed for efficiency and simplicity. The Bridgeline Tape features a semi-resorbable material that transitions from rigid to physiological, promoting better healing and improved patient outcomes.

North America Dominates the Foot and Ankle Devices Market

North America is anticipated to be the dominating region in the foot and ankle devices market. This leadership is driven by advanced healthcare infrastructure, high adoption of innovative technologies, and a high incidence rate of orthopedic diseases, including arthritis and fractures. The improved geriatric population and increased patient awareness of earlier treatment options further propel the market growth within this region. Growing investments in the sector by government bodies and private organizations, followed by favorable regulatory frameworks, increased focus on outpatient surgeries, and advancements in 3D-printed and minimally invasive devices, will sustain the region's leadership in the market. For instance, in December 2022, Enovis Corporation received U.S. Food and Drug Administration (FDA) approval for its STAR Patient Specific Instrumentation (STAR PSI) System, designed for use with the STAR total ankle replacement system. The STAR PSI offers personalized pre-operative planning, providing surgeons with a 3D visualization of the patient's ankle joint and relevant implant information. This system, paired with an updated surgical technique, aims to reduce operative time and improve patient outcomes.

Future Market Scenario (2025-2032F)

Increasing demand for personalized care, which means the utilization of 3D-printed implants and bioresorbable materials, creates growth prospects in the market. Other drivers are the increasing number of robotic-assisted surgery procedures and the introduction of more efficient surgical tools. These are improving patient outcomes and recovery times. Improvement in soft tissue repair devices and a growing focus on outpatient procedures will also contribute to growth in the market. Such strategic partnerships, mergers, investments in R&D, and substantial growth in research and development are likely to propel the market further. For instance, in September 2024, Stryker Corporation expanded its foot & ankle portfolio with the addition of the Osteotomy Truss System (OTS) and Ankle Truss System (ATS) by completing the acquisition of 4WEB Inc. The ATS, designed for tibiotalocalcaneal (TTC) fusions, includes Arthrosphere and Arthrocube implants, using Truss Implant Technology for enhanced structural support and fusion promotion. The OTS offers comprehensive solutions for osteotomies, including Cotton, Evans, and Utility wedges, enhancing surgical options.

In March 2024, Stryker Corporation completed the acquisition of SERF SAS, a French joint replacement company, enhancing its global portfolio. Known for its innovations in hip implants, including the original Dual Mobility Cup, SERF SAS strengthens Stryker's joint replacement offerings. This acquisition expands Stryker's presence in Europe, allowing for broader patient access to advanced implant products and reinforcing its commitment to orthopedic excellence.

Key Players Landscape and Outlook

The global foot and ankle devices market is consolidated, with major global providers dominating a major market share. Recent market developments include product launches, new treatment center setups, and strategic activities like mergers and acquisitions, driving growth and increasing competition.

For instance, in September 2024, Stryker Corporation launched the PROstep MIS Lapidus, an internal fixation system designed for minimally invasive bunion surgery. This system offers enhanced fixation stability through a small incision, utilizing minimally invasive foot and ankle surgery (MIS) joint preparation, triplanar reduction, and a three-screw construct. The system provides a less invasive option for bunion treatment, reducing cosmetic scarring and improving bone healing outcomes. This innovation aligns with the growing adoption of minimally invasive foot and ankle surgery techniques.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Foot and Ankle Devices Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Orthopedic Implants and Devices
      • 4.2.1.1.1. Fixation Devices
        • 4.2.1.1.1.1. Screws
        • 4.2.1.1.1.2. Plates
        • 4.2.1.1.1.3. Wires and Pins
        • 4.2.1.1.1.4. Ring Ankle Fixator
        • 4.2.1.1.1.5. Unilateral Fixator
        • 4.2.1.1.1.6. Others
      • 4.2.1.1.2. Joint Implants
      • 4.2.1.1.3. Soft Tissue Orthopedic Devices
    • 4.2.1.2. Bracing and Support Devices
      • 4.2.1.2.1. Soft Braces and Support Devices
      • 4.2.1.2.2. Hard Braces and Support Devices
      • 4.2.1.2.3. Hinged Braces and Support Devices
    • 4.2.1.3. Soft Tissue and Orthopedic Devices
    • 4.2.1.4. Prosthetics
      • 4.2.1.4.1. Single Axial Prosthetics
      • 4.2.1.4.2. Multiaxial prosthetics
      • 4.2.1.4.3. Others
  • 4.2.2. By Application
    • 4.2.2.1. Osteoarthritis and Rheumatoid Arthritis
    • 4.2.2.2. Neurological Disorders
    • 4.2.2.3. Trauma and Fractures
    • 4.2.2.4. Osteoporosis
    • 4.2.2.5. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Ambulatory Surgery Centers
    • 4.2.3.3. Orthopedic Clinics
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. End-user
  • 4.3.4. By Region

5. North America Foot and Ankle Devices Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Orthopedic Implants and Devices
      • 5.2.1.1.1. Fixation Devices
        • 5.2.1.1.1.1. Screws
        • 5.2.1.1.1.2. Plates
        • 5.2.1.1.1.3. Wires and Pins
        • 5.2.1.1.1.4. Ring Ankle Fixator
        • 5.2.1.1.1.5. Unilateral Fixator
        • 5.2.1.1.1.6. Others
      • 5.2.1.1.2. Joint Implants
      • 5.2.1.1.3. Soft Tissue Orthopedic Devices
    • 5.2.1.2. Bracing and Support Devices
      • 5.2.1.2.1. Soft Braces and Support Devices
      • 5.2.1.2.2. Hard Braces and Support Devices
      • 5.2.1.2.3. Hinged Braces and Support Devices
    • 5.2.1.3. Soft Tissue and Orthopedic Devices
    • 5.2.1.4. Prosthetics
      • 5.2.1.4.1. Single Axial Prosthetics
      • 5.2.1.4.2. Multiaxial prosthetics
      • 5.2.1.4.3. Others
  • 5.2.2. By Application
    • 5.2.2.1. Osteoarthritis and Rheumatoid Arthritis
    • 5.2.2.2. Neurological Disorders
    • 5.2.2.3. Trauma and Fractures
    • 5.2.2.4. Osteoporosis
    • 5.2.2.5. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Ambulatory Surgery Centers
    • 5.2.3.3. Orthopedic Clinics
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Foot and Ankle Devices Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. Product
        • 5.3.1.2.1.1. Orthopedic Implants and Devices
        • 5.3.1.2.1.1.1. Fixation Devices
        • 5.3.1.2.1.1.1.1. Screws
        • 5.3.1.2.1.1.1.2. Plates
        • 5.3.1.2.1.1.1.3. Wires and Pins
        • 5.3.1.2.1.1.1.4. Ring Ankle Fixator
        • 5.3.1.2.1.1.1.5. Unilateral Fixator
        • 5.3.1.2.1.1.1.6. Others
        • 5.3.1.2.1.1.2. Joint Implants
        • 5.3.1.2.1.1.3. Soft Tissue Orthopedic Devices
        • 5.3.1.2.1.2. Bracing and Support Devices
        • 5.3.1.2.1.2.1. Soft Braces and Support Devices
        • 5.3.1.2.1.2.2. Hard Braces and Support Devices
        • 5.3.1.2.1.2.3. Hinged Braces and Support Devices
        • 5.3.1.2.1.3. Soft Tissue and Orthopedic Devices
        • 5.3.1.2.1.4. Prosthetics
        • 5.3.1.2.1.4.1. Single Axial Prosthetics
        • 5.3.1.2.1.4.2. Multiaxial prosthetics
        • 5.3.1.2.1.4.3. Others
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Osteoarthritis and Rheumatoid Arthritis
        • 5.3.1.2.2.2. Neurological Disorders
        • 5.3.1.2.2.3. Trauma and Fractures
        • 5.3.1.2.2.4. Osteoporosis
        • 5.3.1.2.2.5. Others
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Hospitals
        • 5.3.1.2.3.2. Ambulatory Surgery Centers
        • 5.3.1.2.3.3. Orthopedic Clinics
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Foot and Ankle Devices Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Foot and Ankle Devices Market Outlook, 2018-2032F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Foot and Ankle Devices Market Outlook, 2018-2032F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Foot and Ankle Devices Market Outlook, 2018-2032F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

• 17.1. Regulatory Approvals
• 17.2. Innovations

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Orthofix Medical Inc.
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 20.3.2. Stryker Corporation
  • 20.3.3. Zimmer Biomet Holdings, Inc.
  • 20.3.4. Arthrex, Inc.
  • 20.3.5. Johnson & Johnson Services, Inc.
  • 20.3.6. Smith & Nephew plc.
  • 20.3.7. Exactech, Inc.
  • 20.3.8. Acumed LLC
  • 20.3.9. Enovis Corporation
  • 20.3.10. Fillauer Companies, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer